Anorectal Carcinoma After Infliximab Therapy in Crohn’s Disease: Report of a Case

By Melichar Bohuslav   Bureš Jan   Dědič Karel  

Diseases of the Colon & Rectum, Vol. 49, Iss. 8, 2006-08 ,pp. : 1228-1233

Springer Publishing Company

Access to resources Recommend Favorite

Infliximab as a therapy for non-Crohn’s enterocutaneous fistulae

By Date Ravindra   Panesar Kanwar   Neilly Paul  

International Journal of Colorectal Disease, Vol. 19, Iss. 6, 2004-11 ,pp. : 603-606

Springer Publishing Company

Access to resources Recommend Favorite

Infliximab in Drug-Naïve Patients with Failed Ileorectal Anastomosis for Crohn’s Disease: A New Chance for Sparing the Rectum?

By  

European Surgical Research, Vol. 46, Iss. 4, 2011-03 ,pp. : 163-168

Karger

Access to resources Recommend Favorite

MPO-ANCA-Positive Anti-glomerular Basement Membrane Antibody Disease Successfully Treated by Plasma Exchange and Immunosuppressive Therapy

By Murakami Taichi   Nagai Kojiro   Matsuura Motokazu   Kondo Naoki   Kishi Seiji   Araoka Toshikazu   Kishi Fumi   Sakiyama Tsutomu   Mima Akira   Bando Yoshimi   Abe Hideharu   Doi Toshio  

Renal Failure, Vol. 33, Iss. 6, 2011-07 ,pp. : 626-631

Informa Healthcare

Access to resources Recommend Favorite

Ileal perforation in a patient with Crohn’s disease while receiving recombinant human growth hormone therapy

By Wolkersdörfer Gernot   Miehlke Stephan   Schneider Ralph   Ehninger Gerhard   Schiefke Ingolf   Mössner Joachim   Teich Niels  

International Journal of Colorectal Disease, Vol. 22, Iss. 8, 2007-08 ,pp. : 983-984

Springer Publishing Company

Access to resources Recommend Favorite